Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ABX — Abacus Global Management, Inc.
NYSE
FULL STOCK PAGE →

Summary of ABX Q4 2025 Earnings Call

MAR 12, 2026 2 MIN READ
REVENUE
$71.9M +14.2%
NET MARGIN
10.1% -1.2 PTS
EPS
$0.07 +0.4%
FREE CASH FLOW
-$7.6M +77.1%

1Key Financial Results and Metrics

Q4 2025 Revenue: $71.9 million, up 116% year-over-year from $33.2 million.

Full Year 2025 Revenue: $235.2 million, a 110% increase from $111.9 million in 2024.

Adjusted Net Income: Q4 adjusted net income was $23 million, a 71% increase year-over-year; full year adjusted net income was $85.7 million, up 84% from $46.5 million.

Adjusted EBITDA: Q4 adjusted EBITDA reached $38.6 million (132% increase), with a margin of 54%. Full year adjusted EBITDA was $132.6 million (115% increase), maintaining a margin of 56%.

Capital Deployed: $230.7 million in Q4, an 82% increase year-over-year; total capital deployment for 2025 was $580.8 million.

Return on Equity (ROE) and Return on Invested Capital (ROIC): Both at 20% for 2025.

2Strategic Updates and Business Highlights

Market Leadership: ABX has established itself as a leader in the mortality-driven asset space, with a focus on life insurance policies that are uncorrelated to macroeconomic factors.

Data and Technology: The launch of Abacus Intel and the mVerify product has enhanced the company's data capabilities, providing accurate mortality verification and improving underwriting processes.

Acquisition of Manning & Napier: ABX has invested $50 million for a minority stake in Manning & Napier, which is expected to create synergies across wealth management, policy origination, and asset management.

Securitization Strategy: The company launched its first securitization in October 2025 and plans to increase the size of future securitizations based on strong demand.

3Forward Guidance and Outlook

2026 Guidance: ABX projects adjusted net income between $96 million and $104 million, implying growth of up to 22% compared to 2025.

Long-term Goals: By 2028, ABX aims for $250 million in EBITDA and $30 billion in total AUM, with recurring revenue expected to grow from 16% to 60% of total revenue in five years.

4Bad News, Challenges, or Points of Concern

Market Perception: Despite strong financial performance, the company acknowledges a disconnect between its fundamentals and market valuation, which it views as a challenge to overcome.

Increased Competition: As the market for longevity-linked assets grows, competition may intensify, potentially impacting margins and market share.

Securitization Risks: While the initial securitization was successful, future performance will depend on continued investor demand and market conditions.

5Notable Q&A Insights

Securitization Demand: Management indicated strong demand for future securitizations, potentially larger than the initial $50 million offering, driven by market volatility.

Equity Issuance: There is no current intention to raise equity for policy purchases, as the company believes it can fund growth through organic capital generation.

Capital Deployment Strategy: Management emphasized a disciplined approach to capital deployment, focusing on maximizing returns and managing the timing of policy sales.

Growth Drivers: The company plans to leverage both organic growth and strategic acquisitions to achieve its ambitious growth targets, with a focus on enhancing asset management capabilities. Overall, ABX demonstrated robust financial growth in 2025, with a clear strategy for future expansion and an optimistic outlook, despite some challenges related to market perception and competition.

SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT